Recombinant Human Growth Hormone Market Insights Video

According to Cognitive Market Research, the global recombinant human growth hormone market size was USD 6125.6 million in 2024. It will expand at a compound annual growth rate (CAGR) of 4.50% from 2024 to 2031.

• North America held the major market share for more than 40% of the global revenue with a market size of USD 2450.24 million in 2024 and will grow at a compound annual growth rate (CAGR) of 2.7% from 2024 to 2031.
• Europe accounted for a market share of over 30% of the global revenue with a market size of USD 1837.68 million.
• Asia Pacific held a market share of around 23% of the global revenue with a market size of USD 1408.89 million in 2024 and will grow at a compound annual growth rate (CAGR) of 6.5% from 2024 to 2031.
• Latin America had a market share of more than 5% of the global revenue with a market size of USD 306.28 million in 2024 and will grow at a compound annual growth rate (CAGR) of 3.9% from 2024 to 2031.
• Middle East and Africa had a market share of around 2% of the global revenue and was estimated at a market size of USD 122.51 million in 2024 and will grow at a compound annual growth rate (CAGR) of 4.2% from 2024 to 2031.
• The hospital pharmacy held the highest recombinant human growth hormone market revenue share in 2024.